Abstract
The therapeutic effect of ME1228, a new parenteral cephalosporin, was compared with that of broad-spectrum cephems in normal and neutropenic mice infected with various species of bacteria. The results showed that ME1228 was more active than were the other cephems against infections with various pathogens.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Neu H. C., Saha G., Chin N. X. In vitro activity of ME1228, a new parenteral cephalosporin. Antimicrob Agents Chemother. 1989 Aug;33(8):1260–1267. doi: 10.1128/aac.33.8.1260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shibahara S., Okonogi T., Yoshida T., Murai Y., Kudo T., Inouye S., Kondo S. A new aminothiazolylcephalosporin having 1-carboxyethoxyimino group, ME1228. J Antibiot (Tokyo) 1990 Jan;43(1):62–69. doi: 10.7164/antibiotics.43.62. [DOI] [PubMed] [Google Scholar]